-+ 0.00%
-+ 0.00%
-+ 0.00%
Can Krystal Biotech's Gene Therapy Pipeline Finally Justify the Premium Beyond VYJUVEK?
Share
Listen to the news
Barchart +19.44% Beat Sep 2025 $1.12 $2.66 +137.50% Beat Dec 2025 $1.62 $1.70 +4.94% Beat Mar 2026 $1.45 $1.83 +26.21% Beat

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

KRYS typically reports earnings before market open, meaning Day 0 captures the market's immediate reaction during the first trading session, while Day +1 reflects follow-through momentum.

Earnings Date Day 0 Move Day 0 Range Day +1 Move Day +1 Range
2026-05-04 +$20.91 (+7.86%) $35.67 (13.41%) -$2.38 (-0.83%) $19.50 (6.80%)
2026-02-17 +$11.39 (+4.12%) $27.59 (9.98%) -$4.55 (-1.58%) $12.54 (4.36%)
2025-11-03 +$0.34 (+0.17%) $14.96 (7.57%) +$5.41 (+2.73%) $17.52 (8.86%)
2025-08-04 -$22.04 (-14.04%) $23.29 (14.84%) +$2.41 (+1.79%) $6.70 (4.97%)
2025-05-06 -$22.82 (-14.06%) $10.25 (6.32%) -$2.67 (-1.91%) $7.42 (5.32%)
2025-02-19 +$19.48 (+12.43%) $31.98 (20.41%) +$6.45 (+3.66%) $9.32 (5.29%)
2024-11-04 -$5.54 (-3.14%) $10.15 (5.75%) +$3.56 (+2.08%) $5.31 (3.11%)
2024-08-05 -$11.23 (-5.85%) $19.58 (10.20%) -$2.10 (-1.16%) $10.16 (5.62%)
Avg Abs Move 7.71% 11.06% 1.97% 5.54%

Historical price action shows significant volatility around earnings releases, with an average absolute Day 0 move of 7.71% and intraday range of 11.06%. The most recent earnings on May 4, 2026 produced a strong 7.86% gain with a 13.41% intraday range, reflecting positive investor response to the Q1 beat.

The pattern reveals asymmetric outcomes: strong beats tend to drive substantial rallies (February 2025's 12.43% gain, May 2026's 7.86% gain), while disappointments or modest beats can trigger sharp selloffs (August 2025's 14.04% decline, May 2025's 14.06% drop). Day +1 follow-through averages 1.97%, suggesting initial reactions tend to stick rather than reverse.

Investors should prepare for material price movement, particularly given the stock's recent track record of beating estimates. The historical range suggests a move of 8-11% is well within normal parameters, with direction heavily dependent on both the magnitude of any earnings surprise and forward guidance.

Part 2.2: Options Market Expected Move

Metric Value
Expiration Date 08/21/26 (DTE 21)
Expected Move $36.08 (10.59%)
Expected Range $304.68 to $376.84
Implied Volatility 62.66%

The options market is pricing an expected move of 10.59% (±$36.08) for the August 21 expiration, which sits above the historical average Day 0 move of 7.71% but within the typical intraday range of 11.06%. This suggests options traders are anticipating volatility consistent with recent history, though the elevated implied volatility of 62.66% reflects uncertainty about the magnitude and direction of the move.

Part 3: What Analysts Are Saying

Analyst sentiment on KRYS remains overwhelmingly bullish heading into the Q2 report. The consensus rating stands at 4.67 out of 5.0, with 10 Strong Buy ratings, 0 Moderate Buy ratings, 2 Hold ratings, and no sell recommendations among the 12 analysts covering the stock. The average price target of $374.44 implies 9.77% upside from the current price of $341.12, with a high target of $474.00 suggesting some analysts see potential for 39% gains.

The analyst community has maintained its bullish stance, with sentiment classified as unchanged over the past month. All 10 Strong Buy ratings have held steady, as has the Hold count at 2, indicating conviction in the company's commercial trajectory remains firm despite the stock's strong year-to-date performance.

The tight clustering of ratings at the bullish end of the spectrum reflects broad agreement on KRYS's fundamental story. The $190 spread between the high and low price targets ($474.00 vs. $284.00) suggests some variance in assumptions around peak sales potential and pipeline value, but even the most conservative target implies the stock is fairly valued at current levels. The absence of any sell ratings is notable for a stock trading at 47x trailing earnings, underscoring Wall Street's confidence in the durability of the company's growth profile.

Part 4: Technical Picture

The Barchart Technical Opinion currently shows a Buy signal at 80%, down from 100% Buy a month ago but up from 72% Buy last week. This reflects some recent volatility in the technical picture as the stock consolidates near current levels.

Timeframe Analysis:

  • Short-term (50% Buy): Moderate buy signal suggests near-term momentum is positive but not overwhelming, indicating some consolidation after recent gains
  • Medium-term (100% Buy): Strong buy signal across the intermediate timeframe reflects solid upward momentum over the past several weeks
  • Long-term (100% Buy): Maximum bullish reading indicates the longer-term trend remains firmly positive, supporting the overall uptrend

Trend Characteristics: The trend is characterized as Strong but Weakening, suggesting that while the underlying uptrend remains intact, recent price action has introduced some near-term uncertainty heading into the earnings release.

The stock is currently trading at $341.12, positioned below its 5-day ($357.46), 10-day ($346.51), and 20-day ($353.53) moving averages, indicating recent pullback pressure. However, KRYS remains above its 50-day ($337.36), 100-day ($303.78), and 200-day ($271.96) moving averages, confirming the longer-term uptrend is intact. The stock has gained over 25% from its 200-day average, demonstrating strong momentum over the past several months.

Period Value Period Value
5-Day MA $357.46 50-Day MA $337.36
10-Day MA $346.51 100-Day MA $303.78
20-Day MA $353.53 200-Day MA $271.96

The technical setup heading into earnings is mixed: while longer-term trend indicators remain supportive, the recent pullback below short-term moving averages suggests some profit-taking or caution ahead of the report. The stock's position just above the 50-day moving average at $337.36 represents a key support level—a strong earnings beat could propel KRYS back above near-term resistance at the 20-day average, while a disappointment could test the 50-day support. The overall configuration favors bulls on a positive surprise but leaves limited cushion for any disappointment given the recent consolidation pattern.

This article was generated using Barchart’s automated content technology and existing data APIs. As a result, we are able to provide readers with timely, actionable, in-depth analysis on more equities, allowing them to make more informed decisions. All information and data in this article is solely for informational purposes. For more information, please view the Barchart Disclosure Policy here. And, if you would like to report any inaccuracies, please contact news@barchart.com.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending